• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期头颈癌失败模式的变化

Changing patterns of failure in advanced head and neck cancer.

作者信息

Vikram B

出版信息

Arch Otolaryngol. 1984 Sep;110(9):564-5. doi: 10.1001/archotol.1984.00800350006003.

DOI:10.1001/archotol.1984.00800350006003
PMID:6477272
Abstract

We treated 98 previously untreated patients with stages III and IV resectable epidermoid carcinoma of the oral cavity, oropharynx, and larynx with surgery and postoperative radiation therapy. The reasons for postoperative radiation therapy were unsatisfactory surgical margins in 36 patients, cervical metastases at multiple levels pathologically in 49, and both in 13. Historically, patients with similar findings, treated by surgery alone at our institution, had a relapse rate above the clavicles of more than 70% within two years. In the present series only 15% have had relapses above the clavicles, and distant metastases developed in another 20%. In addition, approximately 6% of patients per year have had second malignant neoplasms develop, predominantly in the esophagus or the lung. These changes in the patterns of failure have implications for future studies aimed at improving the cure rate and the survival of these patients.

摘要

我们对98例先前未经治疗的Ⅲ期和Ⅳ期可切除口腔、口咽和喉表皮样癌患者进行了手术及术后放射治疗。术后放射治疗的原因包括:36例手术切缘不满意,49例有多个层面的颈部病理转移,13例两者皆有。从历史数据来看,我院有类似表现的患者若仅接受手术治疗,两年内锁骨以上复发率超过70%。在本系列中,只有15%的患者出现了锁骨以上复发,另有20%发生了远处转移。此外,每年约6%的患者发生了第二原发性恶性肿瘤,主要发生在食管或肺部。这些失败模式的变化对旨在提高这些患者治愈率和生存率的未来研究具有重要意义。

相似文献

1
Changing patterns of failure in advanced head and neck cancer.晚期头颈癌失败模式的变化
Arch Otolaryngol. 1984 Sep;110(9):564-5. doi: 10.1001/archotol.1984.00800350006003.
2
Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications.头颈部鳞状细胞癌的术后放疗:治疗结果与并发症分析
Int J Radiat Oncol Biol Phys. 1989 Jan;16(1):25-36. doi: 10.1016/0360-3016(89)90006-0.
3
The incidence of metastases after multimodal therapy for cancer of the head and neck.头颈部癌多模式治疗后的转移发生率。
Cancer. 1984 Nov 1;54(9):2009-14. doi: 10.1002/1097-0142(19841101)54:9<2009::aid-cncr2820540938>3.0.co;2-3.
4
Risk factors for local-regional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB).头颈部癌(II-IVB期)术前放疗及手术后局部区域复发的危险因素。
Radiology. 2003 Sep;228(3):789-94. doi: 10.1148/radiol.2283012044.
5
Failure at the primary site following multimodality treatment in advanced head and neck cancer.晚期头颈癌多模式治疗后原发部位的治疗失败。
Head Neck Surg. 1984 Jan-Feb;6(3):720-3. doi: 10.1002/hed.2890060303.
6
Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.头颈部鳞状细胞癌患者选择性术后放射治疗后的复发模式。
BMC Cancer. 2016 Mar 7;16:192. doi: 10.1186/s12885-016-2229-x.
7
Second malignant neoplasms in patients successfully treated with multimodality treatment for advanced head and neck cancer.接受晚期头颈癌多模式治疗成功的患者发生的第二原发性恶性肿瘤。
Head Neck Surg. 1984 Jan-Feb;6(3):734-7. doi: 10.1002/hed.2890060306.
8
Outcome of locally advanced stage III and IV head and neck cancer treated by surgery and postoperative external beam radiotherapy.接受手术及术后体外照射放疗的局部晚期III期和IV期头颈癌的治疗结果。
Laryngoscope. 1987 May;97(5):615-20. doi: 10.1288/00005537-198705000-00016.
9
Failure at distant sites following multimodality treatment for advanced head and neck cancer.晚期头颈癌多模式治疗后远处部位的失败情况。
Head Neck Surg. 1984 Jan-Feb;6(3):730-3. doi: 10.1002/hed.2890060305.
10
Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.包括术后放疗以及每周使用多西他赛进行同步化疗在内的多模式治疗,对于口腔癌和口咽癌患者而言是可行且有效的。
Strahlenther Onkol. 2005 Jan;181(1):26-34. doi: 10.1007/s00066-005-1272-3.

引用本文的文献

1
Risk factors of secondary cancer in laryngeal, oropharyngeal, or hypopharyngeal cancer after definitive therapy.根治性治疗后喉癌、口咽癌或下咽癌发生继发性癌症的危险因素。
Int J Clin Oncol. 2024 Feb;29(2):103-114. doi: 10.1007/s10147-023-02433-8. Epub 2023 Dec 7.
2
Antioxidant Use after Diagnosis of Head and Neck Squamous Cell Carcinoma (HNSCC): A Systematic Review of Application during Radiotherapy and in Second Primary Cancer Prevention.头颈部鳞状细胞癌(HNSCC)诊断后的抗氧化剂使用:放疗期间及第二原发性癌症预防应用的系统评价
Antioxidants (Basel). 2023 Sep 12;12(9):1753. doi: 10.3390/antiox12091753.
3
A case of synchronous double cancers consisting of maxillary gingival carcinoma and intraductal papillary mucinous carcinoma, invasive: case report.
上颌牙龈癌和导管内乳头状黏液癌伴浸润的同步双癌 1 例:病例报告。
BMC Oral Health. 2023 Aug 26;23(1):595. doi: 10.1186/s12903-023-03253-y.
4
Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools.头颈部鳞状细胞癌患者的次级原发性恶性肿瘤:27 年诊断工具角度的经验。
PLoS One. 2022 Feb 15;17(2):e0263773. doi: 10.1371/journal.pone.0263773. eCollection 2022.
5
A prospective clinical trial of the second-look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer.经口手术治疗 T1 和 T2 期喉、口咽及下咽癌患者的二次探查前瞻性临床试验。
Cancer Med. 2019 Dec;8(17):7197-7206. doi: 10.1002/cam4.2588. Epub 2019 Oct 8.
6
Novel Molecular Targets for Chemoprevention in Malignancies of the Head and Neck.头颈部恶性肿瘤化学预防的新型分子靶点
Cancers (Basel). 2017 Aug 31;9(9):113. doi: 10.3390/cancers9090113.
7
Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).低剂量13-顺式维甲酸预防头颈部癌第二原发肿瘤的双盲、随机3期试验:东部肿瘤协作组-ACRIN癌症研究组(C0590)试验的长期随访
Cancer. 2017 Dec 1;123(23):4653-4662. doi: 10.1002/cncr.30920. Epub 2017 Aug 7.
8
Retinoid Chemoprevention: Who Can Benefit?维甲酸化学预防:谁能从中受益?
Curr Pharmacol Rep. 2015 Dec 1;1(6):391-400. doi: 10.1007/s40495-015-0036-8. Epub 2015 Apr 15.
9
Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).韩国队列(1993 - 2010年)中头颈部癌后异时性第二原发性恶性肿瘤
PLoS One. 2015 Jul 28;10(7):e0134160. doi: 10.1371/journal.pone.0134160. eCollection 2015.
10
Prognostic impact of second primary tumors in head and neck cancer.头颈部癌中第二原发性肿瘤的预后影响
Eur Arch Otorhinolaryngol. 2016 Jul;273(7):1871-7. doi: 10.1007/s00405-015-3699-1. Epub 2015 Jun 29.